Sale!

CHRNA4 Gene Epilepsy nocturnal frontal lobe type 1 Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The CHRNA4 Gene Epilepsy Nocturnal Frontal Lobe Type 1 Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the CHRNA4 gene, which have been linked to nocturnal frontal lobe epilepsy type 1 (ENFL1). This form of epilepsy is characterized by seizures that predominantly occur during sleep, affecting the frontal lobes of the brain. The CHRNA4 gene plays a crucial role in the regulation of neurotransmitter release in the brain, and mutations in this gene can disrupt normal neurological functions, leading to the development of epilepsy.

Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, this test is essential for individuals exhibiting symptoms of nocturnal frontal lobe epilepsy or those with a family history of the condition. By analyzing a sample of the patient’s DNA, the test can detect specific genetic alterations in the CHRNA4 gene that are responsible for the disorder. This information is invaluable for accurate diagnosis, allowing healthcare providers to tailor treatment plans more effectively and offer genetic counseling to affected families.

The cost of the CHRNA4 Gene Epilepsy Nocturnal Frontal Lobe Type 1 Genetic Test at DNA Labs UAE is 4400 AED. While the price may seem significant, the test offers crucial insights into the genetic basis of the condition, enabling better management and understanding of the disease. It represents a critical step towards personalized medicine in the management of epilepsy, providing patients and their families with hope for more targeted and effective treatments.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CHRNA4 Gene Epilepsy Nocturnal Frontal Lobe Type 1 Genetic Test

Test Name: CHRNA4 Gene Epilepsy Nocturnal Frontal Lobe Type 1 Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for CHRNA4 Gene Epilepsy, Nocturnal Frontal Lobe Type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CHRNA4 Gene Epilepsy, Nocturnal Frontal Lobe Type 1.

Test Details

The CHRNA4 gene is associated with epilepsy, specifically nocturnal frontal lobe type 1 (NFLE1). NFLE1 is a rare form of epilepsy that typically occurs during sleep and is characterized by sudden and often violent movements, vocalizations, and/or seizures.

NGS (next-generation sequencing) genetic testing can be used to analyze the CHRNA4 gene and identify any mutations or variations that may be associated with NFLE1. This type of testing can help with early diagnosis, personalized treatment, and genetic counseling for individuals and families affected by NFLE1.

It is important to note that genetic testing is just one tool in the diagnosis and management of NFLE1, and should always be used in conjunction with clinical evaluation and other diagnostic tests as needed.

Test Name CHRNA4 Gene Epilepsy nocturnal frontal lobe type 1 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for CHRNA4 Gene Epilepsy, nocturnal frontal lobe type 1 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with CHRNA4 Gene Epilepsy, nocturnal frontal lobe type 1
Test Details

The CHRNA4 gene is associated with epilepsy, specifically nocturnal frontal lobe type 1 (NFLE1). NFLE1 is a rare form of epilepsy that typically occurs during sleep and is characterized by sudden and often violent movements, vocalizations, and/or seizures.

NGS (next-generation sequencing) genetic testing can be used to analyze the CHRNA4 gene and identify any mutations or variations that may be associated with NFLE1. This type of testing can help with early diagnosis, personalized treatment, and genetic counseling for individuals and families affected by NFLE1.

It is important to note that genetic testing is just one tool in the diagnosis and management of NFLE1, and should always be used in conjunction with clinical evaluation and other diagnostic tests as needed.